Form 4: Teladoc Health Director Jason Eric Evans Reports Stock Transactions
SEC Form 4 Filing
Director Jason Eric Evans reported the acquisition and disposal of Teladoc Health common stock and derivative securities related to restricted stock units.
Summary
- On December 20, 2024, Jason Eric Evans, a director of Teladoc Health, reported transactions involving the company's stock.
- Evans acquired 1,016 shares of common stock through the conversion of restricted stock units.
- Simultaneously, Evans disposed of 1,016 shares of common stock.
- Following these transactions, Evans directly owns 7,114 derivative securities and 5,081 shares of common stock.
- The restricted stock units were granted on September 20, 2023, and vest over time.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions by a company director, with no inherent positive or negative implications for the company's performance.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and provides transparency to the market regarding the trading activities of Teladoc Health's director.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 09/20/2023 | Reporting person was granted 12,195 restricted stock units. |
| 12/20/2024 | Date of transaction: acquisition and disposal of common stock and derivative securities. |
| 12/23/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.